Important Updates for Investors
Carla Pasternak's Premiere Issue of High-Yield International Just
Released
Income expert Carla Pasternak's debut issue of High-Yield
International covers a Taiwanese manufacturer yielding 9.5%... a
rare Mexican monopoly yielding 13.4%... and other top-performing
investments yielding up to 19.0%.
Government's Biofuel Timetable Could Spell +15,900% Growth
+15,900% growth might seem far-fetched... but it's not. In fact, it
is mandated by law. And I've identified the ONLY stock positioned to
capture this growth.
The
Silver Lining to a Falling Dollar
Despite the U.S. national debt, there is a silver lining for income
investors. This massive spending, combined with movement out of U.S.
Treasuries, is going to take its toll on the dollar, and
international income investors could reap the rewards in the form of
higher dividends. |
|
Overview:
The American Stock Exchange Biotech Index (BTK) is the benchmark index for the
Biotechnology industry. This index was started on October 18, 1991 with a value
of 200.00. The index broke below 100 several times prior to 1999 and then peaked
during 2000 when it briefly reached 800.
Composition:
The BTK is comprised of 17 firms that are chosen to represent the Biotech
sector. The index is relatively unusual in that it is equal-dollar weighted.
This means that each stock receives the same weighting in the index. The index
is rebalanced four times per year to maintain continuity and to keep any stock
from dominating the index's value.
The table below lists the components of the
Biotech Index along with the weighting that each stock carries in the index
(data as of August 2004):
| Company |
Symbol |
%
of Index |
| Protein Design Labs |
PDLI |
6.5% |
| Chiron |
CHIR |
6.5% |
| Enzon Pharmaceuticals |
ENZN |
6.3% |
| Gilead Sciences |
GILD |
6.3% |
| Genzyme |
GENZ |
6.2% |
| MedImmune |
MEDI |
6.2% |
| Biogen IDEC |
BIIB |
6.1% |
| Cephalon |
CEPH |
6.1% |
| Amgen |
AMGN |
6.1% |
| Celgene |
CELG |
5.8% |
| Millennium Pharmaceuticals |
MLNM |
5.7% |
| Celera Genomics |
CRA |
5.7% |
| Genentech |
DNA |
5.5% |
| Affymetrix |
AFFX |
5.5% |
| Human Genome Sciences |
HGSI |
5.5% |
| Vertex Pharmaceuticals |
VRTX |
5.3% |
| Invitrogen |
IVGN |
4.7% |
Positives:
The Biotech Index is an excellent choice for investors who wish to track the
performance of the Biotech sector apart from the broad market. Although it has
been extremely volatile, the Biotech sector has historically outperformed the
overall market, so there is a large amount of interest in this area.
Drawbacks:
Many investors do not like the fact that all of the Biotech Index's component
stocks are equally weighted. This may distort the index's overall returns
because a handful of small companies could have a larger impact on performance
than some of the industry's largest players, such as Amgen (AMGN) and Genentech
(DNA). The index is also somewhat narrowly focused because it only holds 17
firms out of the hundreds of companies that operate in this sector.
How can I trade/invest in this index?
You can invest in the Biotech Index through many different options, futures and
ETFs. However, our favorite way to trade this index is through the Merrill Lynch
Biotech HOLDR (BBH). This fund is relatively liquid and carries a very low
management fee of $0.08 per share per year, which equates to an expense ratio of
less than 0.10% at current prices. This fund has also historically been less
volatile than other funds that attempt to track the Biotech Index, even though
it is dominated in composition by Biotech giants Amgen (AMGN) and Genentech
(DNA). The iShares Biotech fund (IBB) is another tempting choice because it too
is widely traded and contains virtually all Biotech firms (over 100). However,
it does have higher historical volatility than BBH.
Additional Information:
AMEX
Biotech Index - ^BTK
Merrill
Lynch Biotech HOLDR (BBH)
iShares
Nasdaq Biotech Index Fund (IBB)
|
|
Who Cares What the Market is Doing When You're Pulling in $28,900 a
Year in Dividends?
With the safe, growing, high-yield picks that Editor Carla Pasternak
recommends every month you don't have to worry whether or not the
market has bottomed. You can sit back and collect annual dividend
paychecks of $16,300, $19,900 or even $28,900!
You can't go wrong looking into Carla's recommendations. A year from
now, when you've collected as much as $28,900 from dividends alone
you'll be glad you did. Take the first step and,
read this report now.
Seven "Yield Doubler" Stocks That Are Clobbering The Dow
Just 12 trading days before the market hit its 6,500-point low this
year, the "Yield Doublers" portfolio was born. That was
almost 4 months
ago. The Dow has rebounded +12% since then -- but our seven "Yield
Doublers" have clobbered that figure by a factor of up to 9-to-1...
delivering up to +144.2% gains to boot!
Go here to see why you should add these "Yield Doublers" to your
portfolio today.
|
We're
Putting $50,000 on the Line in Our NEW Stock of the Month Portfolio
We're SO confident in this strategy
that we're putting our money where our mouth is... $50,000 worth of it
in fact! That's how much we've put into a brokerage account to fund the
real-money portfolio for StreetAuthority Stock of the Month. Amy
Calistri just made her first purchase, and it's not too late for you to
join in and follow along with everything she does.
Don't
be left on the sidelines, click here to learn more now.
Two
Infrastructure Stocks That Are Profiting From Massive Government
Spending
Since the stimulus package was signed into law on
February 17th, these two infrastructure picks have moved up quickly.
One's a worldwide construction company that's already gained +32% to
date. The other makes critical copper, aluminum and fiber optic
cables... and shot up +41% in a matter of just weeks. Both are headed
higher. You’ll find their names in this special report. |
|
6
Free Months of Bernie Schaeffer's Option Advisor
Learn the secrets of successful options trading from top trader,
Bernie Schaeffer. Start your free 6-month subscription to The Option
Advisor newsletter now and get free online access to Bernie's Crash
Course in Top Gun Trading Techniques.
3
Penny Stocks Poised to Soar 300%
By the time Wall Street notices the 3 picks revealed in this report,
you could be sitting on a fortune. Click
here to get immediate access to an exclusive Free report --
"3 Underground Penny Stocks Poised to Soar."
|
Investor's
Business Daily (IBD)
Get 10 Free Issues of Investor's Business Daily (IBD) – Plus 2
Free Weeks of Investors.com
52 Wins in 52 Weeks - 365 Days Without A Loss
Success Trading Group scored 52 wins in 52 weeks! Get their weekend
newsletters free and register for Success Trading Group's next stock
picks free for 30 days!
|
|
|
|
|
Investing Doesn't Get Any Easier Than This |
Stock picker Amy
Calistri's strategy is as simple as investing gets -- just one idea
a month designed to make money in today's market. Invest this way
and you don't have to worry about oil prices, automaker bailouts, or
what the Fed is up to -- because every "bad" economic development
actually helps some investment or another.Your investing life can
get a lot simpler -- starting today.
Go here to learn about Amy's simple investing strategy.
|
|
|
